SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-11-130840
Filing Date
2011-05-06
Accepted
2011-05-06 16:35:56
Documents
6
Period of Report
2011-06-13

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT dpre14a.htm PRE 14A 897626
2 GRAPHIC g147819g15f30.jpg GRAPHIC 11705
3 GRAPHIC g147819g24c99.jpg GRAPHIC 214249
4 GRAPHIC g147819g26n31.jpg GRAPHIC 191673
5 GRAPHIC g147819g48r72.jpg GRAPHIC 7330
6 GRAPHIC g147819g72x59.jpg GRAPHIC 8241
  Complete submission text file 0001193125-11-130840.txt   1496342
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-14895 | Film No.: 11820184
SIC: 2834 Pharmaceutical Preparations